Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones

Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones

Drug-eluting stent (DES) recipients require 6–12 months of dual antiplatelet treatment (DAPT) and long-term aspirin mono-antiplatelet treatment (MAPT). Given the diversity of contemporary antiplatelet agents, antiplatelet treatment (APT) selection is becoming more complicated. We evaluated 15-year A...

Full description

Bibliographic Details
Main Authors: Sunwon Kim, Jong-Seok Lee, Jungkuk Lee, Yong-Hyun Kim, Jin-Seok Kim, Sang-Yup Lim, Seong Hwan Kim, Jeong-Cheon Ahn, Woo-Hyuk Song
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Clinical Medicine
Subjects:
antiplatelet treatment
clopidogrel
drug-eluting stent
dual-antiplatelet treatment
ticagrelor
Online Access:https://www.mdpi.com/2077-0383/12/7/2675

Internet

https://www.mdpi.com/2077-0383/12/7/2675

Similar Items